UBS ASSET MANAGEMENT AMERICAS INC - CORTEXYME INC ownership

CORTEXYME INC's ticker is CRTX and the CUSIP is 22053A107. A total of 89 filers reported holding CORTEXYME INC in Q4 2020. The put-call ratio across all filers is 4.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of CORTEXYME INC
ValueSharesWeighting
Q3 2021$1,207,987,000
+74.3%
13,179
+0.8%
0.00%
Q2 2021$693,081,000
+169.9%
13,077
+83.5%
0.00%
Q1 2021$256,749,000
-63.7%
7,126
-49.6%
0.00%
Q3 2020$707,400,000
+58.4%
14,148
+46.6%
0.00%
Q2 2020$446,703,0009,6480.00%
Other shareholders
CORTEXYME INC shareholders Q4 2020
NameSharesValueWeighting ↓
EPIQ Capital Group, LLC 3,507,082$97,427,00015.42%
PACIFIC HEIGHTS ASSET MANAGEMENT LLC 225,000$6,251,0000.62%
AtonRa Partners 19,003$528,0000.26%
Alphabet Inc. 189,122$5,254,0000.25%
Ikarian Capital, LLC 170,000$4,722,0000.21%
Burleson & Company, LLC 41,377$1,149,0000.20%
SC US (TTGP), LTD. 1,040,343$28,901,0000.17%
COHEN LAWRENCE B 8,997$250,0000.14%
Intellectus Partners, LLC 13,950$388,0000.12%
Virtus ETF Advisers LLC 9,804$272,0000.11%
View complete list of CORTEXYME INC shareholders